Molecular epidemiological analysis of prostate cancer in Hunan populatio
- Conditions
- prostate cancer
- Registration Number
- ITMCTR2200005999
- Lead Sponsor
- the First Affiliated Hospital of Hunan University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
Patients with undetermined or unknown prostate dynamic tumors requiring prostate needle biopsy. ? Suspicious prostate nodules on digital rectal examination, any prostate-specific antigen values; ? Transrectal prostate ultrasound or MRI found suspicious lesions with normal prostate-specific antigen; ? Prostate specific antigen > 10 ng/ mL; ? Prostate-specific antigen was 4-10 ng/ mL, and free prostate-specific antigen/total free prostate-specific antibody (fPSA/tPSA) was suspicious. Patients in line with the first two criteria should undergo prostate puncture biopsy regardless of the value of psa.
? Patients who have been diagnosed with prostate cancer; ? Patients with serious heart, brain, liver and kidney diseases and intolerance to prostate biopsy; ? Those who are unwilling to receive needle biopsy of prostate.
Study & Design
- Study Type
- Epidemilogical research
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Differential metabolites;
- Secondary Outcome Measures
Name Time Method